Abilify (aripiprazole) has a notably long half-life compared to most medications. The average elimination half-life is about 75 hours (roughly 3 days), meaning it takes approximately 2 to 3 weeks for oral Abilify to fully clear your system after your last dose. If you’re taking a long-acting injectable form, the timeline is dramatically longer.
How the 75-Hour Half-Life Works
A drug’s half-life is the time it takes for the amount in your bloodstream to drop by half. For Abilify, that’s about 75 hours. But your body also converts Abilify into an active metabolite (a breakdown product that still has effects), and that metabolite has an even longer half-life of about 94 hours.
It generally takes five to six half-lives for a drug to be considered effectively eliminated. For Abilify’s parent compound, that math works out to roughly 16 to 19 days. Because the active metabolite lingers longer, trace pharmacological activity can persist for about three weeks after your last oral dose. This also explains why Abilify takes about 14 days of consistent dosing to reach steady-state levels in your blood. Building up and clearing out are both gradual processes with this medication.
Factors That Slow Elimination
Not everyone clears Abilify at the same speed. The biggest variable is genetics. Your liver relies on a specific enzyme (CYP2D6) to break down aripiprazole, and about 8% of Caucasians have a genetic variation that makes this enzyme much less active. These individuals, called poor metabolizers, have an elimination half-life of roughly 146 hours, nearly double the typical 75 hours. That translates to about a month for full clearance instead of two to three weeks. The total drug exposure per dose is also about 60% higher in poor metabolizers, which is why doctors sometimes prescribe lower doses for them.
Age plays a smaller but measurable role. Adults 65 and older clear aripiprazole about 20% more slowly than younger adults, which can add a few extra days to the total elimination window. Other medications can also interfere. Drugs that inhibit the same liver enzyme, including certain antidepressants, can effectively turn a normal metabolizer into a slow one.
Long-Acting Injectables Take Much Longer
If you’ve been receiving Abilify as a long-acting injection (sold as Abilify Maintena or Aristada), the elimination timeline is vastly different from the oral form. These formulations are designed to release aripiprazole slowly from the injection site over weeks. With Aristada (aripiprazole lauroxil), the drug continues entering your bloodstream for roughly 43 to 46 days after each injection, and the mean elimination half-life after the final dose ranges from 54 to 57 days. That means full clearance after a long-acting injectable can take several months, not weeks.
Drug Testing and Detection
Abilify is not a controlled substance and is not included on standard drug screening panels (the kind used for employment or legal purposes). It will not cause a positive result for any commonly tested drug class. Specialized laboratory tests can identify aripiprazole and its metabolites in urine, but these are used almost exclusively to monitor whether patients are taking their medication as prescribed, not in routine screening. In research settings, one metabolite (OPC-3373) showed up in 97% of urine samples from patients on steady-state dosing, while unchanged aripiprazole appeared in only about 58%.
What Discontinuation Feels Like
Because Abilify leaves your system gradually, discontinuation effects tend to follow a predictable pattern. In documented cases, symptoms can begin within about two days of stopping the medication. These have included lightheadedness, nausea, insomnia, irritability, anxiety, muscle twitches, and low mood. The symptoms typically wax and wane over the first several days, then gradually taper off over about two weeks.
The relatively slow decline in blood levels means that abrupt discontinuation is less jarring than it would be with a shorter-acting medication, but it doesn’t eliminate withdrawal effects entirely. The timeline of symptom resolution roughly mirrors the drug’s elimination curve: as levels drop below the threshold needed to occupy receptors in the brain, your nervous system readjusts. For most people taking the oral form, the worst of the transition is over within two to three weeks.